JP2020523375A5 - - Google Patents

Download PDF

Info

Publication number
JP2020523375A5
JP2020523375A5 JP2019569250A JP2019569250A JP2020523375A5 JP 2020523375 A5 JP2020523375 A5 JP 2020523375A5 JP 2019569250 A JP2019569250 A JP 2019569250A JP 2019569250 A JP2019569250 A JP 2019569250A JP 2020523375 A5 JP2020523375 A5 JP 2020523375A5
Authority
JP
Japan
Prior art keywords
selenium
use according
fish oil
amount
hyperthermia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019569250A
Other languages
English (en)
Japanese (ja)
Other versions
JP7336994B2 (ja
JP2020523375A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/037268 external-priority patent/WO2018231938A1/en
Publication of JP2020523375A publication Critical patent/JP2020523375A/ja
Publication of JP2020523375A5 publication Critical patent/JP2020523375A5/ja
Priority to JP2023093883A priority Critical patent/JP2023105154A/ja
Application granted granted Critical
Publication of JP7336994B2 publication Critical patent/JP7336994B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019569250A 2017-06-13 2018-06-13 温熱療法治療を増強するための組成物および方法 Active JP7336994B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023093883A JP2023105154A (ja) 2017-06-13 2023-06-07 がん細胞のpAMPKαまたはCOX-2の含有量を調節するための薬剤の調製のための増感剤の使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762519090P 2017-06-13 2017-06-13
US62/519,090 2017-06-13
PCT/US2018/037268 WO2018231938A1 (en) 2017-06-13 2018-06-13 Compositions and methods for enhancing hyperthermia therapy

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023093883A Division JP2023105154A (ja) 2017-06-13 2023-06-07 がん細胞のpAMPKαまたはCOX-2の含有量を調節するための薬剤の調製のための増感剤の使用

Publications (3)

Publication Number Publication Date
JP2020523375A JP2020523375A (ja) 2020-08-06
JP2020523375A5 true JP2020523375A5 (https=) 2021-07-26
JP7336994B2 JP7336994B2 (ja) 2023-09-01

Family

ID=64562472

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019569250A Active JP7336994B2 (ja) 2017-06-13 2018-06-13 温熱療法治療を増強するための組成物および方法
JP2023093883A Pending JP2023105154A (ja) 2017-06-13 2023-06-07 がん細胞のpAMPKαまたはCOX-2の含有量を調節するための薬剤の調製のための増感剤の使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023093883A Pending JP2023105154A (ja) 2017-06-13 2023-06-07 がん細胞のpAMPKαまたはCOX-2の含有量を調節するための薬剤の調製のための増感剤の使用

Country Status (9)

Country Link
US (3) US10905724B2 (https=)
EP (1) EP3638270B1 (https=)
JP (2) JP7336994B2 (https=)
KR (1) KR102773006B1 (https=)
CN (2) CN120695037A (https=)
CA (1) CA3066742A1 (https=)
IL (1) IL271327B2 (https=)
TW (1) TWI823853B (https=)
WO (1) WO2018231938A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL265786B (en) * 2016-10-03 2022-09-01 Houn Simon Hsia Materials and methods for increasing radiotherapy against cancer
IL271327B2 (en) * 2017-06-13 2024-11-01 Simon Hsia Houn Compositions for increasing tumor sensitivity to hyperthermia therapy
US20220175850A1 (en) * 2019-04-01 2022-06-09 Houn Simon Hsia Compositions and methods for cancer therapy
US20210393579A1 (en) * 2020-06-23 2021-12-23 Zestt Wellness Limited Anthocyanin and Quercetin Based Formulations for Improved Respiratory Health
CN115462488B (zh) * 2022-10-08 2024-01-16 河南师范大学 鞣花酸作为饲料添加剂的应用,功能性饲料及制备方法

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US988092A (en) * 1909-11-22 1911-03-28 Celfor Tool Company Drill.
US4348483A (en) 1981-01-23 1982-09-07 Universal Foods Corporation Method for the production of chromium yeast
US4569836A (en) 1981-08-27 1986-02-11 Gordon Robert T Cancer treatment by intracellular hyperthermia
CA2010511A1 (en) * 1989-03-01 1990-09-01 Roberto L. Ceriani Method of enhancing cancer therapy by administration of unsaturated fatty acids
NZ248605A (en) 1993-05-28 1994-12-22 Abbott Lab Enteral nutritional product comprising protein and fat
US20020010144A1 (en) 1994-04-29 2002-01-24 Robert Sobol Enhancing the sensitivity of tumor cells to therapies
US5976548A (en) 1994-11-08 1999-11-02 Viva America Marketing, Inc. Nutritional supplement composition and use
US6077828A (en) 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US6440464B1 (en) 1996-06-10 2002-08-27 Viva Life Science Nutritive composition for cardiovascular health containing fish oil, garlic, rutin, capsaicin, selenium, vitamins and juice concentrates
US6197295B1 (en) 1996-09-25 2001-03-06 Viva America Marketing Corporation Dietary supplementation with, and methods for administration of yeast-derived selenium product
US5810888A (en) 1997-06-26 1998-09-22 Massachusetts Institute Of Technology Thermodynamic adaptive phased array system for activating thermosensitive liposomes in targeted drug delivery
CA2339473A1 (en) 1998-08-04 2000-02-17 John V. Kosbab Nutrient and therapeutic compositions for the treatment of cancer
AU5319499A (en) * 1999-07-22 2001-02-13 Ivan L. Cameron Fatty acids to minimize cancer therapy side effects
US7569551B2 (en) 2000-02-25 2009-08-04 The University Of British Columbia Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides
US20050080468A1 (en) * 2001-03-26 2005-04-14 Lawrence C. Christman Methods and apparatus for treating diseased tissue
US7731648B2 (en) 2001-07-25 2010-06-08 Aduro Biotech Magnetic nanoscale particle compositions, and therapeutic methods related thereto
EP1438971A4 (en) * 2001-10-25 2005-01-12 Ttc Co Ltd IMMUNE AMPLIFIERS IN THERAPEUTIC THERAPY IN CANCER
US20040087490A1 (en) 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
AU2002951833A0 (en) 2002-10-02 2002-10-24 Novogen Research Pty Ltd Compositions and therapeutic methods invloving platinum complexes
US7744930B2 (en) 2002-11-22 2010-06-29 Shaklee Corporation Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
US8663679B2 (en) 2004-04-29 2014-03-04 Abbott Laboratories Compositions for improving breast health in women
US9107864B2 (en) * 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US20060088574A1 (en) 2004-10-25 2006-04-27 Manning Paul B Nutritional supplements
US20070116802A1 (en) 2005-11-23 2007-05-24 Carl Germano High quality caloric composition
US8017147B2 (en) 2008-04-07 2011-09-13 Mazed Mohammad A Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance
US20090110674A1 (en) 2007-10-24 2009-04-30 Loizou Nicos C Health supplement
WO2009091597A2 (en) 2008-01-16 2009-07-23 Nanospectra Biosciences, Inc. Treatments of disease or disorders using nanoparticles for focused hyperthermia to increase therapy efficacy
WO2009157759A1 (en) 2008-06-23 2009-12-30 N.V. Nutricia Nutritional composition for improving the mammalian immune system
AU2008361497B2 (en) 2008-09-04 2014-07-17 Takeshi Kobayashi Methods and kits for hyperthermia and CTLA4 inhibitory therapy
EP3011843A1 (en) 2008-09-19 2016-04-27 Nestec S.A. Nutritional support of the immune system during anti-cancer treatment
US8257694B2 (en) 2009-05-14 2012-09-04 Product Partners, Llc Nutritional compositions for reducing oxidative damage
KR20120065276A (ko) * 2009-05-29 2012-06-20 뉴 챕터, 인코포레이티드. 지질 조성을 조정하기 위한 조성물 및 방법
KR101275724B1 (ko) 2009-12-09 2013-06-17 한국전자통신연구원 단일 기판 집적 회로 장치 및 그 제조 방법
WO2011094579A2 (en) 2010-01-29 2011-08-04 New Chapter Inc. Mushroom compositions and methods for making and using
JP5882889B2 (ja) 2010-03-15 2016-03-09 国立大学法人 岡山大学 抗腫瘍剤
US20120010688A1 (en) 2010-07-09 2012-01-12 Lamb Karl J Implantable conductive element and method of use inhyperthermic treatment
CN103026807B (zh) 2010-07-26 2016-01-20 莱尔德技术股份有限公司 适用于emi屏蔽应用的具有可控压缩形变的高导电聚合物泡沫的制造处理
US9669053B2 (en) * 2010-07-26 2017-06-06 Chemotherapeutics, Llc Compositions and methods for enhancing the effectiveness of systemic, HIPEC, IP, and related cancer treatments
US9642925B2 (en) 2010-12-07 2017-05-09 Sanford Research/USD Magnetic nanoparticle formulations, methods for making such formulations, and methods for their use
WO2012122295A2 (en) 2011-03-07 2012-09-13 Ned Biosystems, Inc. Treatment for pancreatic adenocarcinoma and other cancers of epithelial origin
CN102349699B (zh) 2011-07-04 2013-07-03 郑俊祥 一种电子烟液的制备方法
US9609457B2 (en) 2012-07-27 2017-03-28 Crexendo, Inc. Mobile application procurement and configuration options for VOIP service
WO2014054884A1 (ko) 2012-10-05 2014-04-10 연세대학교 산학협력단 민감화 물질을 포함하는 온열 치료용 조성물
US9072768B2 (en) 2013-01-22 2015-07-07 Kibow Biotech, Inc. Composition and method for increasing effectiveness of radiation or chemotherapy
US9107947B2 (en) 2013-01-31 2015-08-18 The Penn State Research Foundation Anti-cancer compositions and methods
WO2014159851A2 (en) * 2013-03-13 2014-10-02 The Board Of Regents Of The University Of Texas System Novel low density lipoprotein nanocarriers for targeted delevery of omega-3 polyunsaturated fatty acids to cancer
DE202013002760U1 (de) 2013-03-21 2014-06-23 Cc Pharma Gmbh Nahrungsergänzungsmittel zur medikationsorientierten Supplementierung
US20140294795A1 (en) * 2013-03-28 2014-10-02 Houn Simon Hsia Nutritional Composition
MX370055B (es) * 2013-04-22 2019-11-29 Smartfish As Uso de una composición que comprende aceite de pescado y jugo para el tratamiento y/o postratamiento de cáncer.
SG11201600657RA (en) 2013-07-31 2016-02-26 Meiji Co Ltd Nutritional composition for inhibiting growth of tumor
EP3033091B1 (en) 2013-08-16 2022-09-07 Versitech Limited Probiotic composition and use thereof in the prevention and treatment of hepatocellular carcinoma
CN104082736A (zh) * 2014-06-13 2014-10-08 胡安然 一种调理乳腺癌的方便食品
US20170246136A1 (en) * 2014-09-24 2017-08-31 OliVentures, Inc. Pharmaceutical product, medical food or dietary supplement for preventing cancer and inflammatory diseases
CN105641000A (zh) * 2015-06-01 2016-06-08 深圳市康道生物有限公司 一种含灰树花提取物的抗肿瘤组合物及其制备方法
JP7411327B2 (ja) 2015-11-18 2024-01-11 サイバーグ・コンサルティング・リミテッド・ライアビリティ・カンパニー 天然抽出物を含有する組成物、ならびに皮膚および毛髪に対するその使用
CN105617358A (zh) 2015-12-29 2016-06-01 广州市戴菊科技发展有限公司 一种具有抗肿瘤功能的医用食品及其制备方法
CN105768108A (zh) 2016-03-10 2016-07-20 福格森(武汉)生物科技股份有限公司 一种适用于肿瘤患者服用的特膳食品
JP6376186B2 (ja) 2016-08-04 2018-08-22 トヨタ自動車株式会社 サスペンションメンバ
IL265786B (en) 2016-10-03 2022-09-01 Houn Simon Hsia Materials and methods for increasing radiotherapy against cancer
CN106822560A (zh) 2017-04-07 2017-06-13 湖北工程学院 药物组合物及其制备方法
EP3638269B1 (en) 2017-06-13 2025-12-17 Houn Simon Hsia Nutritional supplement for enhancing cancer radiotherapy
US10905725B2 (en) 2017-06-13 2021-02-02 Houn Simon Hsia Compositions and methods for enhancing cancer chemotherapy
IL271327B2 (en) 2017-06-13 2024-11-01 Simon Hsia Houn Compositions for increasing tumor sensitivity to hyperthermia therapy
JP2020121479A (ja) 2019-01-30 2020-08-13 オリンパス株式会社 射出成形金型

Similar Documents

Publication Publication Date Title
JP2020523375A5 (https=)
Takeishi et al. To wake up cancer stem cells, or to let them sleep, that is the question
Chatran et al. Synergistic anti-proliferative effects of metformin and silibinin combination on T47D breast cancer cells via hTERT and cyclin D1 inhibition
Zang et al. Inhibition of pan-class I phosphatidyl-inositol-3-kinase by NVP-BKM120 effectively blocks proliferation and induces cell death in diffuse large B-cell lymphoma
Blagosklonny Selective anti-cancer agents as anti-aging drugs
Patel et al. Relationship between efficacy outcomes and weight gain during treatment of advanced, non-squamous, non-small-cell lung cancer patients
Zorzi et al. A phase I study of histone deacetylase inhibitor, pracinostat (SB939), in pediatric patients with refractory solid tumors: IND203 a trial of the NCIC IND program/C17 pediatric phase I consortium
JP2016528162A5 (https=)
JP2018508516A5 (https=)
Wu et al. Efficacy and safety of pemetrexed/cisplatin versus gemcitabine/cisplatin as first-line treatment in Chinese patients with advanced nonsquamous non-small cell lung cancer
Marquez-Medina et al. Afatinib: a second-generation EGF receptor and ErbB tyrosine kinase inhibitor for the treatment of advanced non-small-cell lung cancer
Qi et al. Synergistic anti-leukemic interactions between panobinostat and MK-1775 in acute myeloid leukemia ex vivo
JP2018511625A5 (https=)
Kurucu et al. Irinotecan and temozolamide treatment for relapsed Ewing sarcoma: a single-center experience and review of the literature
Vose et al. The Plk1 inhibitor BI 2536 in patients with refractory or relapsed non-Hodgkin lymphoma: a phase I, open-label, single dose-escalation study
Barrientos Idelalisib for the treatment of indolent non-Hodgkin lymphoma: a review of its clinical potential
JP2020523370A5 (https=)
JP2019530706A5 (https=)
Mesa The evolving treatment paradigm in myelofibrosis
Goede et al. Past, present and future role of chlorambucil in the treatment of chronic lymphocytic leukemia
Dómine Gómez et al. Exploratory composite endpoint demonstrates benefit of trilaciclib across multiple clinically meaningful components of myeloprotection in patients with small cell lung cancer
Dubrey et al. Digital clubbing: forms, associations and pathophysiology
Yadav et al. Comparative efficacy of continuous and pulse dose terbinafine regimes in toenail dermatophytosis: A randomized double-blind trial
Correale et al. A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma
ES2656913T3 (es) Endrogenina A y agentes antineoplásicos para el tratamiento de tumores quimiosensibles o quimiorresistentes